Our Businesses

As the world’s third-largest generic and specialty pharmaceutical company, Mylan has a presence in more than 140 countries and territories, including manufacturing, R&D and distribution facilities in North America (United States and Canada); Europe, the Middle East and Africa (EMEA); and the Asia Pacific region (APAC). With a controlling interest in Hyderabad, India-based Matrix Laboratories, Mylan has direct access to the world’s third-largest portfolio of active pharmaceutical ingredients (API). Together, our diverse businesses work toward meeting unmet medical needs across the globe. We invite you to read more about our businesses and visit the Web sites of those linked throughout this section of our Web site to learn more about how Mylan is making a difference in the health of people around the world.